What does Lactic Acid (AHA) do?#
Lactic acid is a gentle alpha-hydroxy acid (AHA) that provides dual benefits: it helps promote smoother skin through exfoliation while also supporting hydration. It is one of the best-tolerated AHAs, a good choice for dry skin thanks to its hydrating properties.
- Helps promote smoother, more refined-looking skin texture
- Supports the skin's natural hydration while exfoliating
- Gentler than glycolic acid, making it a good choice for dry skin thanks to its hydrating properties
How it works
Lactic acid is an alpha-hydroxy acid that gently smooths away dull surface buildup for smoother-looking skin while also supporting hydration. Its dual exfoliating and moisturizing action helps skin look smoother without feeling stripped. It is gentler than glycolic acid, which contributes to a comfortable exfoliating experience.
How to use Lactic Acid (AHA)#
- An evening step, after cleansing and before moisturizer.
- Your routine sets how often to use it — ease off if your skin starts to feel tight.
- Across the whole face in a thin layer, keeping it away from the eye area. Rinse with plenty of water if any gets in your eyes.
- Follow it with a moisturizer.
- A brief tingle on application is common, most often around the nose. It should settle quickly — if it doesn't, stop using it.
- Wear sunscreen every day while you are using it, and for a week after you stop.
- Keep it to a different evening from other exfoliating acids and from retinol.
- Well-suited for those who find glycolic acid too intense.
This product contains an alpha-hydroxy acid (AHA) that may increase your skin's sensitivity to the sun. Wear sunscreen daily while using it and for a week after you stop. Discontinue use if irritation occurs and consult a healthcare provider.
The form you will see it in
Lactic acid exfoliating serum
- Where it goes
- Before moisturizer
Using Lactic Acid (AHA) with other ingredients
Pairs well with Lactic Acid (AHA)
Hyaluronic Acid
Works well togetherBoth support hydration from different angles, complementing lactic acid's dual exfoliant-humectant nature.
Ceramides
Works well togetherCeramides help skin stay comfortable while lactic acid smooths the look of surface texture.
Niacinamide
Works well togetherNiacinamide supports a more even-looking tone and sits comfortably in the same routine as lactic acid.
What not to use with Lactic Acid (AHA)
Azelaic acid
Different timesBoth are active on the skin’s surface and combining them can increase the chance of irritation.
Cysteamine
Different timesThese two are better applied on separate evenings rather than layered together.
Eye-area retinol
Different timesThe eye area is thinner and takes longer to settle, so keep exfoliants to a different evening from your eye retinol.
Other exfoliants
Different timesMore than one exfoliant at once can feel drying, so they’re best kept to separate evenings.
Enzyme Exfoliants · Glycolic Acid (AHA) · LHA · Mandelic Acid (AHA) · PHA (Polyhydroxy Acid) · Salicylic Acid (BHA)
Retinoids
Different timesRetinoids and exfoliants can both feel drying, so they’re best kept to separate evenings.
Vitamin C
Different timesVitamin C and exfoliants are more comfortable at different times than layered in one routine.
Who should avoid Lactic Acid (AHA)?#
Six situations change whether Lactic Acid (AHA) suits your skin right now. Each one is either a reason to skip it, a reason to go slowly, or nothing to watch for.
- Fragile or Sensitive
- Skip it
- Recent Facial or Laser
- Skip it
- Recent Shave or Wax
- Skip it
- Maternity & Nursing
- Go slowly
- Prone to Redness
- Go slowly
- Dry or Itchy Patches
- Go slowly
Maternity & Nursing — If you are pregnant or nursing, you may prefer to check with your healthcare provider before use.
Prone to Redness — Try it on a small area first, and use it less often — or stop — if you notice stinging or extra redness.
Dry or Itchy Patches — Keep the rest of your routine well moisturized, and use it less often — or stop — if you notice tightness or itching.
Cosmetic strength limits for Lactic Acid (AHA) where you live#
| Region | Maximum strength |
|---|---|
| United States | 10% (pH ≥3.5 — guidance, not law) |
| Canada | 18% (total mono-AHA, pH ≥3.5) |
| European Union | 2.5% (pH ≥5.0 — guidance, not law) |
| Great Britain | 2.5% (pH ≥5.0 — guidance, not law) |
These are the maximum strengths allowed or advised in each market — some are set in cosmetics regulation, others are the ceiling a cosmetic safety panel recommends. They are limits, not targets — the right strength for a formula is the formulator's decision.
Products with Lactic Acid (AHA)#
We may earn a small commission when you buy through these links.
Lactic acid exfoliating serum · 1
Common questions about Lactic Acid (AHA)#
When should you apply Lactic Acid (AHA)?
- An evening step, after cleansing and before moisturizer.
How often can you use Lactic Acid (AHA)?
- 3× a week to daily, all over, not the eye area.
Where do you apply Lactic Acid (AHA)?
- All over, not the eye area. Keep it off your lips too.
Does Lactic Acid (AHA) make skin more sensitive to the sun?
- Yes — use sunscreen the next morning.
What should you not use with Lactic Acid (AHA)?
- Space it apart from Azelaic acid, Cysteamine, Eye-area retinol, Other exfoliants, Retinoids and Vitamin C.
Who should avoid Lactic Acid (AHA)?
- Skip it if any of these apply: Fragile or Sensitive, Recent Facial or Laser and Recent Shave or Wax. Go slowly with Maternity & Nursing, Prone to Redness and Dry or Itchy Patches.
Is there a cosmetic limit for Lactic Acid (AHA)?
- Yes. The maximum strength for Lactic Acid (AHA) in a cosmetic is 10% (pH ≥3.5 — guidance, not law) in the United States, 18% (total mono-AHA, pH ≥3.5) in Canada, 2.5% (pH ≥5.0 — guidance, not law) in the European Union and 2.5% (pH ≥5.0 — guidance, not law) in Great Britain. A cap is a limit on the rules, not a signal to use more.
Related ingredients#
How we check this#
Everything on this page traces to the sources listed below — regulators' own publications and published studies. Where the evidence does not answer a question, it is left unanswered.
Some sources below are the official product information for prescription medicines — some contain this ingredient at higher strengths, others are cited for how they interact with it. We use them for their safety and handling detail only. A cosmetic product is not one of those medicines and is not intended to treat any condition.
Our review is AI-assisted and is not a named expert's opinion. Last reviewed August 7, 2026.
Think something here is out of date or wrong? Email us at wiki@skinintelligence.ai with your reasoning and where you read it. We read what people send, and we update the page when the sources support it.
Regulators and official bodies · 16
- S2AMMONIUM LACTATE cream, 12% — FDA-approved prescribing information (SPL), Sun Pharmaceutical Industries; manufactured by Taro. DailyMed setid 9745b6ce-f532-4e80-b6e9-477ab9db4e30, label updated 1 July 2025. Tier 1 (newly fetched for this derivation).
- S9FDA. Guidance for Industry: Labeling for Cosmetics Containing Alpha Hydroxy Acids. Office of the Commissioner / Office of the Chief Scientist, Docket FDA-2000-P-0063, issued January 2005. Tier 1.
- S14SCCNFP. Updated position paper concerning consumer safety of alpha-hydroxy acids, SCCNFP/0799/04, adopted at the 28th plenary meeting, 25 May 2004. Tier 1.
- S16Cosmetic Ingredient Review Expert Panel. Final Report on the Safety Assessment of Glycolic Acid, Ammonium, Calcium, Potassium, and Sodium Glycolates… and Lactic Acid, Ammonium, Calcium, Potassium, Sodium, and TEA-Lactates… Int J Toxicol 1998;17(Suppl 1). DOI 10.1177/109158189801700101. Tier 1. Cited without a personal author: the report is a Panel product and no individual could be confirmed against the DOI record.
- S17Health Canada. Cosmetic Ingredient Hotlist: Prohibited and Restricted Ingredients — List of Ingredients that are Restricted for Use in Cosmetic Products, entry "Alpha-hydroxy acids…", naming Lactic acid, CAS 50-21-5. Tier 1.
- S25Regulation (EC) No 1223/2009 on cosmetic products, Annex III (retained UK text and adopted text as published by legislation.gov.uk). Tier 1. Cited here for an absence: no lactic acid entry.
- S28Roaccutane 20 mg soft capsules — Summary of Product Characteristics, §4.4. electronic medicines compendium, product 100634. Tier 1.
- S29Differin Gel — Summary of Product Characteristics, §§4.4 and 4.5. electronic medicines compendium, product 921. Tier 1.
- S30Treclin 1%/0.025% w/w Gel — Summary of Product Characteristics, §4.4. electronic medicines compendium, product 5371. Tier 1.
- S31RETIN-A (tretinoin) cream / gel — FDA-approved label, Drug Interactions. DailyMed setid 9556d73d-c573-4e0a-9feb-764ce2d1107b. Tier 1.
- S40American Academy of Dermatology. Isotretinoin: The truth about safety, side effects, and skin care. aad.org. Tier 1.
- S41Waldman A, Bolotin D, Arndt KA, Dover JS, Geronemus RG, Chapas A, Iyengar S, Kilmer SL, Krakowski AC, Lawrence N, Prather HB, Rohrer TE, Schlosser BJ, Kim JYS, Shumaker PR, Spring LK, Alam M. ASDS Guidelines Task Force: Consensus Recommendations Regarding the Safety of Lasers, Dermabrasion, Chemical Peels, Energy Devices, and Skin Surgery During and After Isotretinoin Use. Dermatol Surg 2017. PMID 28498204. Tier 1.
- S42Tetralysal 300 mg Hard Capsules — Summary of Product Characteristics, §4.4. electronic medicines compendium, product 926. Tier 1.
- S43NICE. Acne vulgaris: management, NG198, §1.5. Tier 1.
- S49National Rosacea Society. Rosacea Skin Care & Cosmetics. rosacea.org/patients/skincare. Tier 1 (NRS is named at Tier 1 in and is not capped in).
- S51Freederm Gel — Summary of Product Characteristics, pharmacodynamic properties. electronic medicines compendium, product 304. Tier 1.
Studies and references · 41
- S1Feng X, Shang J, Gu Z, Luo X, Chen Y, Liu Y. Lactic Acid Chemical Peeling in Skin Disorders. Clin Cosmet Investig Dermatol 2024. PMID 38682041 · PMC11055559. Tier 2.
- S3Stiller MJ, Bartolone J, Stern R, Smith S, Kollias N, Gillies R, Drake LA. Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photodamaged skin. A double-blind vehicle-controlled clinical trial. Arch Dermatol 1996. PMID 8651713. Tier 2.
- S4Smith WP. Epidermal and dermal effects of topical lactic acid. J Am Acad Dermatol 1996. PMID 8784274. Tier 2.
- S5Rawlings AV, Davies A, Carlomusto M, Pillai S, Zhang K, Kosturko R, Verdejo P, Feinberg C, Nguyen L, Chandar P. Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function. Arch Dermatol Res 1996;288:383–90. PMID 8818186. Tier 2.
- S6Grove G, Zerweck C. An evaluation of the moisturizing and anti-itch effects of a lactic acid and pramoxine hydrochloride cream. Cutis 2004. PMID 15027519. Tier 2.
- S7Draelos Z, Lewis J, McHugh L, Pellegrino A, Popescu L. Novel retinoid ester in combination with salicylic acid for the treatment of acne. J Cosmet Dermatol 2016. PMID 26516077. Tier 2.
- S8Igarashi A, Abe M, Gunji Y, Nemoto O, Kawamura K, Yokozeki M, Saito A, Ookawara A. Evaluation of a Dermocosmetic Serum Containing a Multi-acid Complex and Niacinamide in Japanese Women with Mild Acne. J Clin Aesthet Dermatol 2025. PMID 40256337. Tier 2.
- S10Cosmetic Ingredient Review Expert Panel. Safety Assessment of Alpha Hydroxy Acids as Used in Cosmetics — re-review package, released 15 November 2013, incorporating the 1998 Final Report on the Safety Assessment of Glycolic Acid… and Lactic Acid… (Int J Toxicol 1998;17(Suppl 1):1–241). cir-safety.org/sites/default/files/ahas.pdf. Recorded in the vault at Tier 2; CIR is named at Tier 1 in, and the SAGE record of the 1998 Final Report [16] is held at Tier 1. Individual study attributions inside it (Frosch & Kligman 1977; Middleton 1974; Vilaplana et al. 1992; Yu & Van Scott 1996; ESLUR 1994a; DiNardo 1994) are as printed in the CIR document and were not independently author-verified against a PMID.
- S11Smith WP. Comparative effectiveness of alpha-hydroxy acids on skin properties. Int J Cosmet Sci 1996. PMID 19245467. Tier 2.
- S12Okuda M, Donahue DA, Kaufman LE, Avalos J, Simion FA, Story DC, Sakaguchi H, Fautz R, Fuchs A. Negligible penetration of incidental amounts of alpha-hydroxy acid from rinse-off personal care products in human skin using an in vitro static diffusion cell model. Toxicol In Vitro 2011. PMID 21871557. Tier 2.
- S13Berardesca E, Distante F, Vignoli GP, Oresajo C, Green B. Alpha hydroxyacids modulate stratum corneum barrier function. Br J Dermatol 1997;137:934–8. PMID 9470910. Tier 2.
- S15Garg T, Ramam M, Pasricha JS, Verma KK. Long term topical application of lactic acid/lactate lotion as a preventive treatment for acne vulgaris. Indian J Dermatol Venereol Leprol 2002. PMID 17656910. Tier 2.
- S18Wollenberg A, Barbarot S, Torrelo A. Basic Emollients for Xerosis Cutis in Atopic Dermatitis: A Review of Clinical Studies. Int J Dermatol 2025. PMID 40265493 · PMC12124105. Tier 2.
- S19Smith WP. The effects of topical l(+) lactic acid and ascorbic acid on skin whitening. Int J Cosmet Sci 1999. PMID 18505528. Tier 2.
- S20Sachdeva S. Lactic acid peeling in superficial acne scarring in Indian skin. J Cosmet Dermatol 2010. PMID 20883299. Tier 2 (professional peel — quarantined).
- S21Sahu P, Dayal S. Most worthwhile superficial chemical peel for melasma of skin of color: Authors' experience of glycolic, trichloroacetic acid, and lactic peel. Dermatol Ther 2021. PMID 33372385. Tier 2 (professional peel — quarantined).
- S22Malviya A, Shrivastava S, Pancholi S, Hassanandani T, Kumar V, Dhakad JS. A Prospective Study Comparing Clinical Efficacy of 30% Mandelic Acid Peel Versus 30% Lactic Acid Peel in Periorbital Melanosis. Indian Dermatol Online J 2025. PMID 41051381. Tier 2 (professional peel — quarantined).
- S23Bjerring P, Draelos ZD, Fabi SG, Goodman GJ, Hau KC, Haus A, Heydenrych I, Kim J, Lin LC, Sayed K, Sundaram H, Tsubouchi R. International Expert Consensus on Integrated Skincare Active Ingredients for Pretreatment and Posttreatment Use With Medical Aesthetic Procedures to Enhance Skin Benefits. J Cosmet Dermatol 2026. PMID 42087526 · PMC13145317. Tier 2.
- S24Kornhauser A, Coelho SG, Hearing VJ. Applications of hydroxy acids: classification, mechanisms, and photoactivity. Clin Cosmet Investig Dermatol 2010. PMID 21437068 · PMC3047947. Tier 2.
- S26Rendl M, Mayer C, Weninger W, Tschachler E. Topically applied lactic acid increases spontaneous secretion of vascular endothelial growth factor by human reconstructed epidermis. Br J Dermatol 2001. PMID 11453900. Tier 2.
- S27Glycolic Acid. Drugs and Lactation Database (LactMed), NCBI Bookshelf NBK500912. Tier 2 (NCBI Bookshelf). Cited for the sibling AHA — no LactMed record for lactic acid was located.
- S32Badenhorst T, Svirskis D, Wu Z. Physicochemical characterization of native glycyl-l-histidyl-l-lysine tripeptide for wound healing and anti-aging: a preformulation study for dermal delivery. Pharm Dev Technol 2016. PMID 25384620. Tier 2.
- S33Topical AHA in Dermatology: Formulations, Mechanisms of Action, Efficacy, and Future Perspectives. Cosmetics 2023;10(5):131, MDPI. Tier 2. Cited without authors: no PMID or could be confirmed for this record.
- S34Dampa E. The Effectiveness of Topical Keratolytics (Alpha Hydroxy Acids/Beta Hydroxy Acids/Urea) in Treating Keratosis Pilaris: A Review of the Literature. Cureus 2025. PMID 41631232 · PMC12860576. Tier 2.
- S35Sjöberg T, Letasiova S, Jankovskaja S, Hrapovic N, Österlund C, Nilsson E, Engblom J, Spégel P, Björklund S. Effect of pH on niacinamide skin permeation. Sci Rep 2026. PMID 41872243 · PMC13018549. Tier 2.
- S36Hu M, Tu Y, Man MQ, He Y, Wu P, He L, Gu H. Rosacea and seborrheic dermatitis differentially respond to lactic acid sting and capsaicin tests in Chinese women. J Cosmet Dermatol 2023. PMID 37464957. Tier 2.
- S37Fanning J, Jacob C, Diaz I, Ibrahim O. Treatment of mild-to-moderate facial cutaneous aging using a combination peel containing 6% trichloroacetic acid and 12% lactic acid. J Cosmet Dermatol 2023. PMID 37227430. Tier 2 (professional peel — quarantined).
- S38Ly S, Kamal K, Manjaly P, Barbieri JS, Mostaghimi A. Treatment of Acne Vulgaris During Pregnancy and Lactation: A Narrative Review. Dermatol Ther (Heidelb) 2023. PMID 36447117 · PMC9823189. Tier 2.
- S39Trivedi MK, Kroumpouzos G, Murase JE. A review of the safety of cosmetic procedures during pregnancy and lactation. Int J Womens Dermatol 2017. PMID 28492048 · PMC5418954. Tier 2.
- S44Anitha B. Prevention of complications in chemical peeling. J Cutan Aesthet Surg 2010. PMID 21430836 · PMC3047741. Tier 2.
- S45Arif T. Salicylic acid as a peeling agent: a comprehensive review. Clin Cosmet Investig Dermatol 2015. PMID 26347269 · PMC4554394. Tier 2.
- S46American Society for Dermatologic Surgery. Chemical Peels — patient information, "What can I expect after having a chemical peel?" asds.net. Tier 3 ( is tier-capped at 3 in; the cap outranks the vault's recorded tier).
- S47Chemical Peels for Skin Resurfacing — Contraindications. StatPearls, NCBI Bookshelf NBK547752. Tier 2.
- S48Li Q, Xu Y, Shu H, Li N, Gu H, He L, Tu Y. Lactic acid sting test and capsaicin test differentially induce facial erythematous reaction in subjects with sensitive skin. J Cosmet Dermatol 2024. PMID 38059312. Tier 2.
- S50Lyu J, Diao QC, Wang S, Yu Y, Jiang Y. Study on screening and evaluation methods of cosmetics for people with facial sensitive skin. Medicine (Baltimore) 2022. PMID 35945772. Tier 2.
- S52Finholt P, Higuchi T. Rate studies on the hydrolysis of niacinamide. J Pharm Sci 1962;51:655–61. PMID 13892959. Tier 2. No abstract is indexed; cited for the existence of the classical amide-hydrolysis rate work only, not for a number.
- S53Jennings MB, Alfieri D, Ward K, Lesczczynski C. Comparison of salicylic acid and urea versus ammonium lactate for the treatment of foot xerosis. A randomized, double-blind, clinical study. J Am Podiatr Med Assoc 1998. PMID 9680769. Tier 2.
- S54Unlocking the Potential of Fermentation in Cosmetics: A Review. Fermentation 2023;9(5):463, MDPI. Tier 2. Cited without authors: not confirmed at time of writing.
- S55Ascorbic Acid in Skin Health. Cosmetics 2019;6(4):58, MDPI. Tier 2. Cited without authors: not confirmed at time of writing.
- S56NeoGlucosamine vs benzoyl peroxide acne poster, re-hosted PDF. Tier 4 — not usable as evidence. The host is banned in as a site re-hosting someone else's PDF. Listed here only to record that the 8% NAG vs 8% glycolic cell-turnover comparison referenced under partner 4.8 rests on a banned source and therefore contributes nothing to that verdict, which stands as NO EVIDENCE.
- S57Yoshimura K, Momosawa A, Aiba E, Sato K, Matsumoto D, Mitoma Y, Harii K, Aoyama T, Iga T. Clinical trial of bleaching treatment with 10% all-trans retinol gel. Dermatol Surg 2003. PMID 12562345. Tier 2.




